VACCIBODY DNA VACCINE PLATFORM VB10.NEO INDUCES STRONG NEO-ANTIGEN SPECIFIC CD8+ T CELL RESPONSES CRITICAL TO CURE ESTABLISHED TUMORS IN PRE-CLINICAL MODELS